CONTENT

Destacados

HIVACAT

Effect of PEG-Interferon alfa 2a on T-cell activation markers in HIV/HCV chronically infected individuals

Financing entity: ORVACS

Participant entities: Fundació IrsiCaixa

Investigador(s) extern(s): C. Tural

Cell Virology and Immunology